These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 34348002)

  • 1. Defective Natural Killer Cells in Melanoma: Role of NKG2D in Pathogenesis and Immunotherapy.
    Touboul R; Zaravinos A; Bonavida B
    Crit Rev Immunol; 2021; 41(2):45-76. PubMed ID: 34348002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Boosting Natural Killer Cell-Mediated Targeting of Sarcoma Through DNAM-1 and NKG2D.
    Sayitoglu EC; Georgoudaki AM; Chrobok M; Ozkazanc D; Josey BJ; Arif M; Kusser K; Hartman M; Chinn TM; Potens R; Pamukcu C; Krueger R; Zhang C; Mardinoglu A; Alici E; Temple HT; Sutlu T; Duru AD
    Front Immunol; 2020; 11():40. PubMed ID: 32082316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-vitro IL-2 or IFN-α-induced NKG2D and CD161 NK cell receptor expression indicates novel aspects of NK cell activation in metastatic melanoma patients.
    Konjević G; Mirjačić Martinović K; Vuletić A; Babović N
    Melanoma Res; 2010 Dec; 20(6):459-67. PubMed ID: 20938360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic and functional characteristics of blood natural killer cells from melanoma patients at different clinical stages.
    Fregni G; Messaoudene M; Fourmentraux-Neves E; Mazouz-Dorval S; Chanal J; Maubec E; Marinho E; Scheer-Senyarich I; Cremer I; Avril MF; Caignard A
    PLoS One; 2013; 8(10):e76928. PubMed ID: 24204708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro increased natural killer cell activity of metastatic melanoma patients with interferon-α alone as opposed to its combination with 13-cis retinoic acid is associated with modulation of NKG2D and CD161 activating receptor expression.
    Konjevic G; Mirjacic-Martinovic K; Vuletic A; Babovic N
    J BUON; 2012; 17(4):761-9. PubMed ID: 23335538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NK Cells Expressing a Chimeric Activating Receptor Eliminate MDSCs and Rescue Impaired CAR-T Cell Activity against Solid Tumors.
    Parihar R; Rivas C; Huynh M; Omer B; Lapteva N; Metelitsa LS; Gottschalk SM; Rooney CM
    Cancer Immunol Res; 2019 Mar; 7(3):363-375. PubMed ID: 30651290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-vitro activation of natural killer cells from regional lymph nodes of melanoma patients with interleukin-2 and interleukin-15.
    Vuletić AM; Jovanić IP; Jurišić VB; Milovanović ZM; Nikolić SS; Tanić NT; Konjević GM
    Melanoma Res; 2015 Feb; 25(1):22-34. PubMed ID: 25380182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural killer lysis receptor (NKLR)/NKLR-ligand matching as a novel approach for enhancing anti-tumor activity of allogeneic NK cells.
    Markel G; Seidman R; Besser MJ; Zabari N; Ortenberg R; Shapira R; Treves AJ; Loewenthal R; Orenstein A; Nagler A; Schachter J
    PLoS One; 2009; 4(5):e5597. PubMed ID: 19440333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bispecific antibody-mediated redirection of NKG2D-CAR natural killer cells facilitates dual targeting and enhances antitumor activity.
    Zhang C; Röder J; Scherer A; Bodden M; Pfeifer Serrahima J; Bhatti A; Waldmann A; Müller N; Oberoi P; Wels WS
    J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34599028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarkers of suppressed natural killer (NK) cell function in metastatic melanoma: decreased NKG2D and increased CD158a receptors on CD3-CD16+ NK cells.
    Konjević G; Mirjacić Martinović K; Jurisić V; Babović N; Spuzić I
    Biomarkers; 2009 Jun; 14(4):258-70. PubMed ID: 19489688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of cytokines on NK cell activity and activating receptor expression in high-risk cutaneous melanoma patients.
    Martinović KM; Milićević M; Larsen AK; Džodić R; Jurišić V; Konjević G; Vuletić A
    Eur Cytokine Netw; 2019 Dec; 30(4):160-167. PubMed ID: 32096478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New avenues for melanoma immunotherapy: Natural Killer cells?
    Cristiani CM; Garofalo C; Passacatini LC; Carbone E
    Scand J Immunol; 2020 Apr; 91(4):e12861. PubMed ID: 31879979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased expression of NKG2D, NKp46, DNAM-1 receptors, and intracellular perforin and STAT-1 effector molecules in NK cells and their dim and bright subsets in metastatic melanoma patients.
    Mirjačić Martinović KM; Babović NLj; Džodić RR; Jurišić VB; Tanić NT; Konjević GM
    Melanoma Res; 2014 Aug; 24(4):295-304. PubMed ID: 24769842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of several activating and inhibitory receptors on CD3(-)CD56(+) NK cells in regional lymph nodes of melanoma patients.
    Vuletić A; Jurišić V; Jovanić I; Milovanović Z; Nikolić S; Konjević G
    J Surg Res; 2013 Aug; 183(2):860-8. PubMed ID: 23522458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural killer group 2D receptor and its ligands in cancer immune escape.
    Duan S; Guo W; Xu Z; He Y; Liang C; Mo Y; Wang Y; Xiong F; Guo C; Li Y; Li X; Li G; Zeng Z; Xiong W; Wang F
    Mol Cancer; 2019 Feb; 18(1):29. PubMed ID: 30813924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation and Phenotypic Characterization of Tumor-Infiltrating NK Cells in Skin Carcinoma.
    Arjmand B; Hamidpour SK; Tayanloo-Beik A; Arjmand R; Rezaei-Tavirani M; Aghayan H; Rajaeinejad M; Larijani B
    Methods Mol Biol; 2024; 2849():215-226. PubMed ID: 38329617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-2 And IL-15 Induced NKG2D, CD158a and CD158b Expression on T, NKT- like and NK Cell Lymphocyte Subsets from Regional Lymph Nodes of Melanoma Patients.
    Vuletić A; Jovanić I; Jurišić V; Milovanović Z; Nikolić S; Spurnić I; Konjević G
    Pathol Oncol Res; 2020 Jan; 26(1):223-231. PubMed ID: 29948616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reovirus infection of tumor cells reduces the expression of NKG2D ligands, leading to impaired NK-cell cytotoxicity and functionality.
    Khaleafi R; Zeleznjak J; Cordela S; Drucker S; Rovis TL; Jonjic S; Bar-On Y
    Front Immunol; 2023; 14():1231782. PubMed ID: 37753084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody targeting tumor-derived soluble NKG2D ligand sMIC reprograms NK cell homeostatic survival and function and enhances melanoma response to PDL1 blockade therapy.
    Basher F; Dhar P; Wang X; Wainwright DA; Zhang B; Sosman J; Ji Z; Wu JD
    J Hematol Oncol; 2020 Jun; 13(1):74. PubMed ID: 32517713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Germline Variants in Natural Killer Cells With Tumor Immune Microenvironment Subtypes, Tumor-Infiltrating Lymphocytes, Immunotherapy Response, Clinical Outcomes, and Cancer Risk.
    Xu X; Li J; Zou J; Feng X; Zhang C; Zheng R; Duanmu W; Saha-Mandal A; Ming Z; Wang E
    JAMA Netw Open; 2019 Sep; 2(9):e199292. PubMed ID: 31483464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.